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• Mex3a is expressed in a subset of Lgr5+ cells that proliferate slowly 
 
• Mex3a+ cells are multipotent and can generate all intestinal lineages 
 
• Mex3a+ cells can convert to fast-dividing ISCs to maintain homeostasis 
 




ETOC:   
Lgr5+ intestinal stem cells are considered to be a homogenous and rapidly proliferating 
population.  Barriga et al. show that the RNA binding protein Mex3a defines a subset of 
slowly proliferating Lgr5+ cells that contribute to all intestinal lineages with slow 
kinetics, are resistant to chemotherapy, and support intestinal regeneration.  
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SUMMARY  
Highly proliferative Lgr5+ stem cells maintain the intestinal epithelium and are thought 
to be largely homogenous.  While quiescent intestinal stem cells (ISCs) populations 
have been described, the identity and features of such a population remain 
controversial.  Here we report unanticipated heterogeneity within the Lgr5+ ISC pool.  
We found that expression of the RNA-binding protein Mex3a labels a slowly cycling 
subpopulation of Lgr5+ ISCs that contribute to all intestinal lineages with distinct 
kinetics.  Single cell transcriptome profiling revealed that Lgr5+ cells adopt two discrete 
states, one of which is defined by a Mex3a expression program and relatively low 
levels of proliferation genes.  During homeostasis, Mex3a+ cells continually shift into 
the rapidly dividing, self-renewing ISC pool.  Chemotherapy and radiation preferentially 
target rapidly dividing Lgr5+ cells but spare the Mex3a-high/Lgr5+ population, helping 
to promote regeneration of the intestinal epithelium following toxic insults.  Thus, 
Mex3a defines a reserve-like ISC population within the Lgr5+ compartment.  
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INTRODUCTION 
The small intestine is the fastest self-renewing tissue in mammals (Clevers, 2013). 
Cells are generated within invaginations of the epithelium called crypts, migrate rapidly 
towards the surface and die at the tip of finger-like protrusions known as villus. This 
whole process takes less than a week. In homeostasis, cell loss in the villus is 
compensated by continuous cell production in crypts. The rapid cellular turnover of the 
intestine is powered by Lgr5+ intestinal stem cells (ISCs) that reside at the bottommost 
positions of the crypts (Barker et al., 2007). Lgr5+ cells actively proliferate and give rise 
to progenitors that differentiate as they reach the top of the crypts. Large numbers of 
absorptive cells (enterocytes) and mucosecreting cells (goblet cells) that populate the 
intestinal epithelium are generated by amplification of the progenitor pool through 
several rounds of cell division before differentiation. A subset of progenitor cells 
undergo differentiation to Paneth cells, which remain intermingled with Lgr5+ cells at 
the base of the crypt. In addition, the small intestine contains three low abundance cell 
types; Enteroendocrine cells which are hormone secreting cells scattered throughout 
the crypt and villus, Microfold (M) cells which line the Peyer patches and initiate 
mucosal immunity and Tuft cells which are dedicated to sense and trigger responses to 
helminth parasites. Enteroendocrine, M- and Tuft cells in the intestine represent less 
than 1 epithelial cell in every 100.      
Lgr5+ ISCs proliferate as a homogenous cell pool (Snippert et al., 2010), with a rate of 
about 1 division per day (Barker et al., 2007). Such high proliferation rate, renders 
Lgr5+ ISCs sensitive to DNA and cytostatic damage (Tao et al., 2015). Despite single 
cell profiling supported the absence of heterogeneity in Lgr5+ cell population (Grün et 
al., 2015), the intestine displays a remarkable capacity to recover from these insults, 
suggesting the existence of reserve or facultative stem cells in a relatively quiescent 
state. Numerous studies have proposed that quiescent ISCs occupy the +4 crypt 
position and express markers such as Bmi1, mTert, Lrig1 or Hopx (Montgomery et al., 
2010; Powell et al., 2012; Takeda et al., 2011; Yan et al., 2012). Yet, the existence and 
identity of such quiescent ISCs has been largely controversial (Muñoz et al., 2012) and 
remains a matter of debate. It was also shown that upon damage of the Lgr5+ pool, 
committed progenitor cells undergo dedifferentiation and act as facultative stem cells 
by regenerating the ISC compartment. For example, Alpi+ enterocytes act as 
facultative stem cells upon genetic ablation of Lgr5+ cells (Tetteh et al., 2016). 
Likewise, crypt progenitors that express the Notch ligand Dll1 give rise to secretory 
cells in homeostatic conditions yet they produce Lgr5+ ISCs upon radiation-induced 
damage of the intestine (van Es et al., 2012). Secretory cell progenitors are slow 
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proliferating, retain DNA labels and are relatively resistant to chemotherapeutic drugs 
(Buczacki et al., 2013).  
Mex3a belongs to the Mex3 family which in mammals contains four members encoded 
by different genes: Mex3a, Mex3b, Mex3c and Mex3d. Mex3 proteins have highly 
conserved RNA binding domains and a C-terminal RING finger domain with E3 
ubiquitin ligase activity (Buchet-Poyau et al., 2007). The role of Mex genes in mammals 
is largely unknown, yet their C. elegans homologue – mex3 -, is required for germline 
stem cell identity and maintenance (Ciosk et al., 2006) whereas human MEX3A has 
been correlated to stemness in colon cancer cell lines (Pereira et al., 2013). Here we 
report that Mex3a labels a subpopulation of slow proliferating progenitor cells located 
around +3/+4 crypt position. In homeostatic conditions, Mex3a-high cells give rise to 
cells that differentiate to all intestinal lineages with low output. A substantial proportion 
of Mex3a-high cells also produce rapidly proliferating ISCs in homeostasis. Upon 
damage of the intestinal epithelium with chemotherapy or irradiation, Mex3a-high cells 
are spared and a larger proportion of this population contributes to regenerate the 




Characterization of Mex3a-expressing intestinal cells 
We compared the specific transcriptional programs of ISCs of the mouse small 
intestine (Muñoz et al., 2012), mouse large intestine and human colon (Jung et al., 
2011) (Fig S1A. and Table S1). These three sets of ISCs were characterized by 
expression of canonical intestinal stem cell markers such as Lgr5 (Barker et al., 2007), 
Ascl2 (van der Flier et al., 2009), EphB3 (Batlle et al., 2002) and Smoc2 (Muñoz et al., 
2012). We focused our attention on the RNA binding protein Mex3a, which was 
enriched in the three types of ISCs yet it had not been previously studied in the 
intestine. We confirmed by RT-qPCR that Mex3a was upregulated in human and 
mouse ISCs (Figure S1B). By RNAscope in situ hybridization (ISH) on small intestine 
tissue we found that Mex3a mRNA was restricted to crypt base columnar cells (CBCs) 
(Figure 1A). Most CBCs displayed low levels yet about half of the crypts in each 
histological section contained 1 to 3 CBCs with relative higher Mex3a mRNA 
abundance (Figure 1B). Quantification revealed that Mex3a-high cells were 
preferentially located at the crypt position +3 near the boundary of the Paneth cell 
compartment (Figure 1C). To analyze functionally the population of cells that express 
Mex3a, we generated mice bearing a transcriptional reporter cassette knocked-in at the 
start codon of the Mex3a locus. The reporter cassette consisted in tdTomato and 
CreERT2 cDNAs separated by self-cleavage T2A peptide (Figure 1D, Figure S1C). 
We termed this mouse strain Mex3aTom-CreERt2/+ (from now on referred to as Mex3aTom/+). 
Mex3aTom/+ were born at mendelian ratios, had normal lifespans, were fertile, and 
showed no overt phenotype. Analysis of reporter expression in the small intestine 
revealed Tomato positive (Tom+) cells positioned at the crypt base. The expression of 
the reporter was low, which is in agreement with the low endogenous levels of Mex3a 
mRNA detected by RT-qPCR and ISH. We observed cells with higher Tomato levels 
located most frequently near to uppermost Paneth cells, i.e. the +3/+4 crypt region 
(Figure 1D). In flow cytometry analysis of dissociated crypt-enriched epithelial cells, 
approximately 4% were Tom+. We defined the Tom-high cell population as the top 
20% brightest cells of the Tom+ fraction, which correspond to about 1% of all crypt 
cells (Figure 1E). Given that each crypt is formed by 200-300 epithelial cells, this 
threshold coincides with 2-3 Tom-high cells per crypt, which is roughly the frequency of 
Mex3a-high cells observed by ISH. Indeed, Tom-high cells expressed highest levels of 
Mex3a mRNA (Figure 1F).  
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Genes driven by WNT signaling in ISCs such as Lgr5, Ascl2, Axin2, Fzd2 or Smoc2 
were expressed at similar levels in Mex3a-high compared to Mex3a-low cells whereas 
Mex3a-neg cells displayed several fold lower expression (Figure 1F). In contrast, 
expression of markers of mucosecreting and enterocyte differentiation was highest in 
the Mex3a-negative cell population (Figure 1G). We also assessed the expression of 
putative +4 ISC markers. We observed a small yet consistent enrichment in Bmi1 and 
Tert in Mex3a-high cells (Figure 1H). To further define the phenotype of Mex3a-
expressing cell populations, we performed transcriptomics of Mex3a-high, -low and –
neg cells (Table S2). Gene ontology analysis showed that Mex3a-high cells were 
enriched in genes encoding secretory cell functions, hormone metabolic processes and 
also in genes that regulate negatively the cell cycle (Figure 1I, Table S3). This profile 
differed substantially from that of Lgr5-high cells, which were characterized by 
expression of genes that promote mitosis, Wnt signaling and biosynthetic processes as 
previously reported (Figure 1I, Table S3)(Muñoz et al., 2012).  
 
Mex3a-high cells are slow proliferating  
In agreement with the expression of a gene program of negative regulation of cell 
proliferation in Mex3a-high cells, we confirmed high levels of the cyclin-dependent 
kinase inhibitors p57 (Cdkn1c) and p21 (Cdkn1a) in Mex3a-high cells (Figure 2A). To 
study the proliferative status of Mex3a-expressing cells in vivo, we interrogated 
Cyp1a1::H2B-YFP mice which express H2B-YFP under the control of the beta-
naphthoflavone-inducible Cyp1a1 promoter in all epithelial intestinal cells except for 
Paneth cells. In pulse-chase experiments, only long-lived slow proliferating cells retain 
the H2B-YFP label after 10 days of induction with beta-napthoflavone (Buczacki et al., 
2013). Label-retaining cells (LRCs) were characterized by elevated levels of both 
Mex3a and Lgr5 (Figure 2B). Analysis of the transcriptomes of LRCs revealed 68 
genes specifically upregulated in LRCs (H2B-YFP+ compared to H2B-YFP- cells and 
to Paneth cells, Table S4). This LRC signature was very significantly enriched in 
Mex3a-high cells (Figure 2C). We confirmed expression of LRC-specific genes such 
as Rfx6 and Peg3 by RT-qPCR in Mex3a-high cells (Figure 2D).  
To functionally validate the association of Mex3a-high cells with LRCs, we crossed 
Cyp1a1::H2B-YFP mice with Mex3aTom/+ mice and analyzed the distribution of the two 
reporters in compound mice. We had previously demonstrated that high surface 
abundance of the receptor tyrosine kinase EphB2 identify cells at the bottommost 
positions of the crypt and enable the isolation of ISCs from mouse and human intestine 
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(Jung et al., 2011; Merlos-Suárez et al., 2011). Pulse chase-experiments demonstrated 
that Mex3a-high/EphB2-high cells retained H2B-YFP compared to the Mex3a-
neg/EphB2-high cell population (Figure 2E, 2F). Within H2B-YFP retaining cells, LRC 
gene expression was largely restricted to the Mex3a-high population (Figure S2A). We 
also performed classical DNA labeling of proliferative cells using the nucleotide 
analogue EdU (Figure 2G). These experiments confirmed that Mex3a-high cells 
retained about 15 fold more EdU than Mex3a-neg cells 10 days after labeling (Figure 
2H). From these experiments, we concluded that Mex3a marks a population of slow 
proliferating cells within the crypt base.  
 
Lineage tracing from Mex3a-high cells 
We next sought to analyze the contribution of Mex3a-high cells to intestinal 
homeostasis (Figure 3). To this end, we crossed Mex3aTom/+ mice to Rosa26 mTmG 
mice (Muzumdar et al., 2007). In this mouse model, induction with tamoxifen switches 
on the activity of Mex3a-driven CreERT2, which in turn activates the expression of 
membrane bound GFP (GFP) in Mex3a-expressing cells and their progeny. In parallel, 
we analyzed the dynamics of Lgr5+ cells using Lgr5GFP/+; Rosa26RLacZ mice (Figure 
S3A). These experiments were performed in conditions that trigger recombination in 
one cell per crypt. We focused our analysis in the small intestine and first established 
the initial position of Mex3a-derived clones. 36 hours after induction, around 80% of 
clones were located just above or below the uppermost Paneth cells, within the crypt 
+3/+4 region (Figure 3A). Lineage tracing from the Lgr5GFP/+ mice showed a 
distribution of labeled cells complementary to that observed in Mex3aTom/+ mice at this 
early time point, i.e. 80% of LacZ+ cells were positioned at the crypt base whereas the 
rest marked +3/+4 crypt cells (Figure 3A). Thus, the initial position of Mex3a+ clones 
coincided approximately with that of cells expressing highest levels of Mex3a mRNA 
(Figure 1A, 1D). However, we could only find about 1 recombined (GFP+) cell every 
700 crypts and this frequency remained in a similar range over the first month of tracing 
despite the progressive increase in clone size (Figure 3B). Thus, recombination of the 
Rosa26 mTmG reporter allele only occurred in a small fraction of Tomato-CreERT2 
expressing cells, which probably reflects poor Cre recombinase activity as a result of 
low expression of the Mex3a locus. Nevertheless, we confirmed that creERT2 mRNA 
was largely restricted to Mex3a-high cells (Figure S3B) implying that most traces 
originate from this population. We also found that clones arising 3 days post tamoxifen, 
which were mostly composed of one or two cells, retained higher levels of Mex3a and 
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p57 mRNA compared to non-recombined cells (Figure S3C). To overcome the 
limitations imposed by the low frequency of recombination and capture the behavior of 
the whole Mex3a+ cell population, we assessed a large number of clones for each time 
point in subsequent experiments (n=56-331 clones; Figure 3B).  
Clones generated by Mex3a+ cells increased progressively in size yet displayed slow 
growth kinetics compared to those produced by Lgr5+ cells (Figure 3C-D). At 3 days of 
tracing around 80% of GFP+ clones in Mex3aTom/+ mice appeared as one or two labeled 
cells around crypt +3/+4 region (Figure 3C and examples in 3G). At 7 days, 
approximately 50% of clones were still composed of 1 or 2 cells whereas only one third 
had expanded beyond 20 cells (Figure 3C and examples in Figure 3H). At this time 
point, most clones within crypts remained localized at +3/+4 position (Figure 3E) and 
included one or two CBCs (Figure 3F). In contrast, Lgr5+ cells generated clones that 
after 7 days appeared as ribbons of cells that expanded from the crypt base up to the 
villus tip (Figure 3D and examples in Figure S3E). This pattern is generated by the 
rapid and continuous proliferation of ISCs as described elsewhere (Barker et al., 2007; 
Lopez-Garcia et al., 2010). Importantly, we did not observe a single ribbon in 
Mex3aTom/+ mice at 7 days of tracing implying that we did not initially mark any fast 
dividing ISCs. However, ribbons equivalent to those observed in Lgr5GFP/+ mice 
appeared after 14 days of tamoxifen induction and progressively became more 
abundant up to the point that they were the only clone type present at 28 days (Figure 
3C, example in S3E). Quantification of clone number per crypt indicated that 
frequency decreased progressively until day 28 to then stabilize coinciding with the 
preponderance of ribbon clones (Figure 3B). Analysis of clone position in Mex3aTom/+ 
mice showed that the majority migrated into the villus over a period of two weeks yet 
some clones remained in the crypt even after 14 days (Figure 3E). These delayed 
clones may result from either slow cell migration or simply represent new clones 
generated by traced Mex3a+ cells. Altogether, these observations suggest that Mex3a 
labels a population of slow dividing progenitor cells. The emergence of ribbon clones 2 
weeks after tamoxifen induction implies that a substantial fraction of Mex3a+ cells or of 
their progeny give rise to rapidly proliferating ISCs in homeostatic conditions. 
We next studied the cell composition of the clones formed by Mex3a+ cells. At 3 days 
post-induction, the majority of single cells and small clones were located within the 
crypt. None expressed differentiation markers (n=59 clones; Figure 4A). At 1 week, 60 
% of clones had migrated into the upper region of the crypt and the villus (Figure 3E). 
Villus clones formed by 1 or 2 cells expressed DCLK1, CHGA or ANPEP implying 
differentiation towards tuft, enteroendocrine or adsorptive lineages respectively 
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(examples Figure 4B, S4A). Multi-cell clones (3-20 cells) were composed of both 
absorptive (ANPEP+) and mucosecreting cells (MUC2+) (examples Figure 4C). 6 
clones out of 241 analyzed contained Paneth cells located at the crypt base (examples 
in Figure S4B). Quantification revealed approximately a 3:1 ratio of absorptive versus 
secretory cell differentiation (Figure 4D). Those clones that after 7 days remained 
positioned near the crypt base did not express differentiation makers (examples in 
Figure 4E, S4C, S4D). From these results, we conclude that similarly to Lgr5+ ISCs, 
Mex3a-high cells generate multilineage progeny albeit with low output.  
 
Mex3a is expressed in a subset of Lgr5+ cells 
To explore the relationship between Mex3a+ and Lgr5+ cell populations, we crossed 
Mex3aTom/+ mice with the Lgr5GFP/+ strain (Barker et al., 2007) and analyzed the 
distribution of the two fluorescent reporters in crypt cells of the small intestine. Previous 
studies had shown that Lgr5-high cells represent ISCs whereas Lgr5-low cells are early 
transient amplifying cells (van der Flier et al., 2009). GFP-negative cells are not 
informative of Lgr5 mRNA as a result of mosaicism in transgene expression in these 
mice (Schuijers et al., 2014). We thus limited our analyses to the distribution of Mex3a-
Tomato within the Lgr5-GFP+ gate. Lgr5-high/Mex3a-high cells represented around 
5% of total GFP cells and Lgr5-low/Mex3a-high cell represented around 4% of total 
GFP cells. (Figure 5A, Figure S5A). Thus, 1 in every 5 Lgr5-high and 1 in every 16 
Lgr5-low cells are Mex3a-high.  
We measured expression of marker genes by RT-qPCR across the 6 cell populations 
defined by Mex3a-Tomato and Lgr5-GFP levels (Figure 5B-D and Table S5). ISC-
specific and WNT-driven genes were elevated in Lgr5-high cells regardless of Mex3a 
expression. Mex3a mRNAs were highest in Mex3a-high/Lgr5-high cells (Figure 5B). 
Paneth cell-specific genes such as Defa and Lyz1 were expressed in Mex3a-high/Lgr5-
high cells (Figure 5D) yet levels of these genes were 80 fold lower in Mex3a-high cells 
than in mature Paneth cells (Figure S5C). Consistent with our previous data, Mex3a-
high cell populations contained 2-3-fold more Bmi1 mRNA (Figure S5B). 
The Lgr5-low cell population was characterized by reduced expression of ISC/WNT 
genes and elevated levels of markers of intestinal differentiation as previously reported 
(Figure 5B-C) (van der Flier et al., 2009). Mucosecreting (Muc2+/Tff3+) and absorptive 
progenitor cells (Alpi+) were captured in Lgr5-low/Mex3a-low and Lgr5-low/Mex3a-neg 
gates implying that these cells represent transient amplifying cells (Figure 5C). Dll1+ a 
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marker of secretory precursors, was in the limit of detection yet it did not show 
differential expression between subpopulations (Figure S5B). Interestingly, Lgr5-
low/Mex3a-high cell population expressed genes characteristic of low abundant 
lineages; tuft cells (Dclk1), enteroendocrine cells (Chga) and M cells (Spib) (Figure 
5D). Altogether, these expression patterns indicate that Mex3a-high/Lgr5-high cells 
resemble ISCs with an incipient expression of genes characteristic of both Paneth and 
rare secretory cells.  Of note, most of the clones observed in lineage tracing 
experiments using the Mex3aTom driver probably originated from Mex3a-high/Lgr5-high 
population as inferred from the observation that these cells expressed highest levels of 
creERT2 (Figure 5B).  
We next assessed the clonogenic potential of Mex3a/Lgr5 subpopulations using as 
readout their ability to form in vitro organoids (Sato et al., 2009). As previously 
reported, Lgr5-high cells showed highest organoid forming capacity in media 
supplemented with RSPO1, EGF and NOGGIN (Sato et al., 2009). We found, however, 
that Mex3a-high/Lgr5-high formed 3-fold and 10-fold more organoids than Mex3a-
low/Lgr5-high and Mex3a-neg/Lgr5-high cell populations respectively (Figure 5E, 5F). 
Organoids generated from Mex3a-high/Lgr5-high cells contained all intestinal lineages 
(Figure 5G) and could be maintained during multiple passages (n=8) implying self-
renewal and multilineage differentiation potential.  Finally, to test whether Mex3a-
high/Lgr5-low cells could gain clonogenic potential under conditions that promote self-
renewal, we enforced WNT and NOTCH signaling using CHIR99021 and valproic acid, 
two small molecules that maximize signaling from these pathways in the absence of 
ligands (Yin et al., 2014). In these conditions, cells remain blocked in an ISC-like state 
as indicated by the formation of spheroids yet Mex3a-high/Lgr5-low and Mex3a-
low/Lgr5-low remained poorly clonogenic (Figure S5D).  
Single cell transcriptomics identifies a subpopulation of Lgr5-high cells enriched 
in the Mex3a signature. 
The finding that a subset of Lgr5-high cells expresses Mex3a and that Mex3a-
high/Lgr5-high display slow proliferation kinetics implies heterogeneity of the ISC pool. 
Our data contrast with recent single cell transcriptomic analysis of Lgr5-high cells (Grün 
et al., 2015), which concluded that this population is largely homogenous. Indeed, we 
reanalyzed the Grün dataset and failed to identify an obvious Lgr5+ subpopulation 
expressing the Mex3a-specific signature. We, however, reasoned that this negative 
result might simply be due to underrepresentation of the Mex3a population as the Grün 
dataset contained sequences of only 53 individual Lgr5-high cells at a relatively low 
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coverage (mean of 0.4 million reads per cell). Therefore, we set out to generate 
transcriptomic data for a larger number of Lgr5-high cells at a higher sequencing depth. 
To this end, the top 25% of brightest Lgr5-GFP+ cells from the small intestine were 
isolated and loaded into a high-throughput microfluidic chip. We generated single cell 
transcriptomic profiles by RNA sequencing of 400 capture sites. Subsequently, we 
excluded both empty capture sites and those sites that contained visually identified cell 
doublets. Additionally, we applied stringent quality control filters to further discard cells 
showing either low quality sequencing data or transcript distributions that scored with 
elevated probability of belonging to cell aggregates (see methods for details). The final 
high-quality dataset contained 245 individual Lgr5-high cells sequenced at an average 
of 1.8 million reads per cell (Figure 6A). We identified unique transcripts (using unique 
molecular identifiers, UMIs) and assessed cell population distribution using principal 
component analysis (PCA). Unsupervised analysis grouped Lgr5-high cells into two 
well-defined clusters. Cluster 1 and cluster 2 contained 140 and 105 Lgr5-high cells 
respectively (Figure 6B). Optimal cluster number was not affected by coverage as 
shown by downsampling analysis (Figure S6A), yet a reduction of cell numbers below 
50% precluded the identification of the two Lgr5-high cell populations (Figure S6B). 
We estimated that the classification (out-of-bag) error of cells into the two predefined 
cell clusters increased upon downsampling of the number reads per cell below 20% 
(Figure S6C). Analysis of the dataset based on t-distributed stochastic neighbor 
embedding (tSNE) also grouped Lgr5-high cells in two clusters (Figure S6E-G).  Thus, 
a minimal number of cells with sufficient coverage are required to identify heterogeneity 
within the Lgr5-high cell population.  
The ISC-specific genes Lgr5, Smoc2, Olfm4 and Axin2 were expressed at equal levels 
in cluster 1 and 2 (Figure 6C). Furthermore, the average level of the Lgr5-GFP-high 
specific gene expression signature was equivalent in the two clusters (Figure 6D and 
Figure S6E). Therefore, both cluster 1 and 2 contain bonafide Lgr5-high cells. Lowly 
expressed genes such as Mex3a, Tert or Dll1 were captured with very low coverage in 
our dataset (i.e. an average of 0.24, 0.06, and 0.47 UMIs per cell respectively), which 
precluded reaching reliable conclusions about their expression pattern. However, we 
found that the Mex3a-high signature was largely upregulated in cells belonging to 
cluster 2 (Figure 6E and Figure S6F). Genes upregulated in Mex3a-high/Lgr5-high 
cells compared to Mex3a-neg/Lgr5-high cells were also enriched in cluster 2 (Table S6 
and Figure S6H). We found no correlation between expression levels of Lgr5-high and 
Mex3a-high signatures (Figure 6F). 
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The above data imply that cluster 2 contains Lgr5-high cells that express the gene 
program characteristics of Mex3a-high cells. Additionally, the PCA plots showed that 
the Mex3a gene program was expressed in a graded manner; this is, it increased as 
cells from cluster 2 separate from cluster 1 along principal component 1 (PC1). We 
found that the graded expression of the Mex3a program correlated inversely with a 
signature characteristic of Ki67+ crypt cells (corr: -0.38; p value: 7.8 x 10-10) (Figure 
6G, 6H) obtained from Ki67-RFP knock-in mice (Table S6), (Basak et al., 2014) which 
is enriched in genes required for mitosis and progression through the cell cycle. 
Indeed, Cluster 1 and 2 in the PCA and tSNE plots differed in the expression levels of 
the Ki67 signature (Figure 6G and S6G). Therefore, as Lgr5-high cells become 
progressively Mex3a positive they lower expression of the proliferation program.            
Finally, a recent study has identified a subset of Lgr5-high cells characterized by 
incipient expression of makers of both of absorptive and secretory lineages. It was 
proposed that these “primed” Lgr5-high cells, termed intestinal bipotent progenitors 
(IBPs), may represent ISCs undertaking the first step toward differentiation before 
commitment to either lineage (Kim et al., 2016). We used genes enriched in IBPs to 
identify this population in our dataset and confirmed that a fraction of Lgr5-high cells 
expressed markers of both absorptive and secretory lineages. IBP-like cells were 
present in both cluster 1 and 2 and therefore they did not represent a main source of 
cell heterogeneity in the PCA (Figure S6I).  
Mex3a-expressing cells are resistant to both chemotherapy and γ-radiation 
Standard chemotherapy and γ-radiation treatments are aimed at killing rapidly dividing 
cells. A main example is 5-Fluorouracil (5FU), which blocks thymidine synthesis thus 
impeding DNA replication. γ-radiation induces double strand breaks in all cell types, 
albeit with higher toxicity in highly proliferative cells. Consistent with this notion, 
treatment of mice with both high dose 5FU and IR reduced significantly the Lgr5-high 
cell population (Figure 7A-B, Figure S7A). In contrast, the frequency of Mex3a-high 
cells increased upon treatment (Figure 7A-B, Figure S7B). Analysis of compound 
Mex3aTom/+; Lgr5GFP/+ mice showed that Mex3a-high/Lgr5-high cells were more resistant 
to 5-FU and IR than Lgr5-high/Mex3a-low and Lgr5-high/Mex3a-neg cells (Figure 7C, 
7D). Mex3a expression also segregated Lgr5-low cells according to their sensitivity to 
5-FU and IR. These experiments also showed that Lgr5-low/Mex3a-neg cells, which 
represent the bulk of the transient amplifying compartment, were highly sensitive to 
these insults whereas the relative numbers of Lgr5-low/Mex3a-high and Lgr5-
low/Mex3a-low cells increased upon treatment (Figure 7C, 7E). Therefore, the majority 
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of Lgr5-high and Lgr5-low cells that resisted 5FU expressed Mex3a. As we assessed 
cell numbers 48 hours after treatment, the observed frequencies likely reflect relative 
survival rates rather than proliferation and subsequent expansions of each 
subpopulation. 
We next studied the contribution of Mex3a-high cells to tissue renewal upon 
chemotherapy by mapping their fate using lineage tracing analysis. We did not find 
significant differences in clone size or numbers at early time points of treatment 
(Figure S7C, S7D). Importantly, 1 week after 5FU treatment, Mex3a+ cells produced 
larger clones, including 10% of ribbons that were never present in untreated mice at 
this time point (Figure 7F, 7G). All clones produced in control or 5FU-treated 
Mex3aTom/+ mice arose from +3/+4 crypt region, except for ribbons that started below 
within the crypt base (Figure S7E). Two weeks after 5FU treatment, the percentage of 
crypt base-to-villus ribbons generated by Mex3a-high cells increased by over two fold 
compared to controls (Figure 7G). These patterns fit well with the notion that Mex3a-
high cells are not only relatively resistant to chemotherapy but also contribute to 
regenerate the rapidly proliferating ISC pool after damage.  
 
DISCUSSION 
The features and behavior of Mex3a+ cells are unique among other previously 
characterized crypt cell populations. Mex3a-high cells resemble Lgr5+ crypt base 
columnar cells in that they express high levels of WNT-driven ISC-specific genes. 
However, the progeny of Mex3a-high cells originates largely from +3/+4 crypt region 
and is substantially less abundant than that produced by bulk Lgr5+ cell population 
during equivalent periods. Mex3a+ cells generate multilineage progeny and therefore 
they do not represent progenitor committed to particular lineages. Dll1, Dclk1, Ngn3 or 
Alpi mark short-lived progenitor cells that differentiate towards particular lineages 
(Nakanishi et al., 2013; van Es et al., 2012; Wang et al., 2007). None of these 
populations contribute long-term to renewal of the epithelium in homeostatic conditions. 
In contrast, a large fraction of Mex3a population is recalled to the ISC pool and 
regenerates the epithelium over months.  
Mex3a-high cells display features reminiscent of crypt Label Retaining Cells (LRCs) 
originally identified by Chris Potten (Potten et al., 1978) and later characterized by the 
Winton lab (Buczacki et al., 2013). The observation that the H2B-YFP mark that 
accumulates in LRCs is inherited by enteroendocrine and Paneth cells led to the 
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proposal that these cells are precursors of these secretory lineages (Buczacki et al., 
2013). Experiments of lineage-tracing using a bipartite Cre recombinase in which the 
enzyme is reconstituted only in label retaining cells indicated that this cell population 
does not retain clonogenic capacity in homeostasis (Buczacki et al., 2013). Similarly to 
LRCs, Mex3a-high cells accumulate nucleotide analogues as a result of their low 
proliferation rates and display incipient expression of Paneth Cell markers. Yet, Mex3a-
derived clones contain larger proportion of absorptive cells, which reflect the greater 
abundance of this cell type in the small intestine, and therefore Mex3a+ progeny is not 
biased towards the secretory lineage. More importantly, unlike LRCs described by 
Winton and colleagues (Buczacki et al., 2013), Mex3a-high cells or its progeny produce 
ribbon clones in homeostatic conditions implying long-term clonogenic potential. The 
reasons for the discrepancy between the behavior of H2B-YFP-retaining cells reported 
in the previous study (Buczacki et al., 2013) and that of the Mex3a-high cells described 
herein are unclear but indicate that these two populations are not completely 
overlapping. A potential confounding effect is the fact that Mex3a-high cells include 
both Lgr5-high and Lgr5-low populations. Mex3a-high/Lgr5-high cells express the 
ISC/WNT program and are highly clonogenic ex vivo. In contrast, Mex3a-high/Lgr5-low 
cells are characterized by higher levels of enteroendocrine and tuft cell genes and give 
rise organoids with very low efficiency. We thus speculate that lineage tracing from the 
bipartite cre/H2B present in the previous study (Buczacki et al., 2013) may largely 
reflect the behavior of the Mex3a-high/Lgr5-low population. Testing this hypothesis will 
require generation of genetic tools that enable fate mapping from each of these two 
populations.  
Single cell transcriptomic analysis revealed previously unanticipated heterogeneity of 
Lgr5-high cell pool. Our data indicates that two classes of Lgr5-high cells co-exist 
within the crypt base. Both are marked by genes that define canonical ISCs whereas 
cluster 2 cells are enriched in the gene program specific of Mex3a+ cells. The average 
expression of the Mex3a signature is anti-correlated with that of Ki67+ progenitor cells, 
an observation that fits in well with the limited cellular output generated by Mex3a+ 
cells in lineage tracing experiments. Nevertheless, the Ki67 program is not fully 
silenced in cluster 2 cells, which is in agreement with Lgr5-high/Mex3a-high cells being 
slow proliferating rather than fully quiescent. Thus, single cell expression data reflects 
to a large extent rapid versus slow proliferative states adopted by ISCs. Based on the 
graded levels of Mex3a-specific gene signature across cluster 2 cells, we speculate 
that some cluster 1 cells may progressively acquire the slow diving Mex3a+ phenotype. 
As the Lgr5-driven creERT2 marks both rapid and slow proliferating ISCs, lineage 
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tracing alleles specific of cluster 1 cells will be required to track conversion between 
these two states.  
It is important to consider that as a consequence of their lower division rates, Mex3a-
high cells have a modest contribution to sustain renewal of the epithelium under 
homeostatic conditions. According to the lineage tracing experiments, individual cells 
and small clones derived from Mex3a-high cells last for about two to three weeks 
suggesting that this is the approximate life-span of the Mex3a-high cell population. This 
data fits in well with the possibility that slow proliferating Mex3a-high cells are 
continuously displaced by the rapidly dividing ISCs as a result of the neutral 
competition dynamics that drive renewal of the intestinal epithelium (Snippert et al., 
2010). An alternative explanation for the long residence time of Mex3a-derived clones 
in crypts would be that over a period of two weeks, Mex3a+ cells keep producing new 
progeny, which is observed as individual cells or small cell clones in each experimental 
time point. Importantly, a fraction of Mex3a-derived cells are converted to rapidly 
proliferating ISCs as shown by the emergence of crypt base-to-villus clones (“ribbons”) 
in two weeks tracing experiments. The fact that we never observed ribbon-like clones 
before this period implies that Mex3a-driven creERT2 does not initially mark fast 
dividing ISCs.  
Finally, Mex3a cells are largely resistant to chemotherapy and radiotherapy when 
compared to bulk Lgr5+ ISCs (Tao et al., 2015). This property is likely the 
consequence of their relative slow proliferation rates. In addition, the observation that 
isolated Mex3a-high/Lgr5-high cells display enhanced organoid formation capacity may 
suggest that this cell population adapts particularly well to stress conditions such as 
those present in ex vivo cultures. We show that upon 5FU treatment, the rate of 
conversion of Mex3a-high cells to ISCs is exacerbated. Mounting evidence indicates 
that Dll1+ secretory progenitors (van Es et al., 2012) and even differentiated 
enterocytes (Tetteh et al., 2016) exhibit plasticity and regain stemness upon depletion 
of the Lgr5+ pool. Yet, we argue that reversion of differentiated cells to a stem cell 
state is probably a rare event that does not contribute substantially to regenerate the 
epithelium after chemotherapy or radiation. Indeed, De Sauvage and colleagues 
demonstrated that Lgr5+ cell population is necessary to regenerate the epithelium 
upon irradiation (Metcalfe et al., 2014). Our experiments show that chemotherapy and 
radiation eliminates preferentially Mex3a-neg/Lgr5-low cell population, which contains 
the bulk of transient amplifying cells in the crypt. In contrast, the Mex3a+ cell 
population continues to generate progeny immediately after 5FU treatment. In these 
conditions, about 40% of Mex3a-high cells produce ribbon-like clones implying that a 
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large proportion contribute to generate the compartment of fast dividing Lgr5+ ISCs. 
Given the fact that Mex3a-high/Lgr5-low cells show little clonogenic capacity in ex vivo 
assays, we favor the idea that resilient Mex3a-high/Lgr5-high cells contribute the most 
to regeneration after damage. Therefore Mex3a-high cells represent a reservoir of 
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Figure 1: Characterization of Mex3a-expressing intestinal cells. 
(A) ISH of Mex3a expression in mouse small intestine. (Left panel) Representative 
staining of Mex3a in proximal mouse small intestine. Scale bar represents 50 µm. 
(Right panel) High magnification of small intestine crypt stained for Mex3a mRNA 
expression. The position of crypt-base columnar cells is shown. Red arrowheads point 
to Mex3a-high CBCs and black arrowheads point to Mex3a-low CBCs. Blue P refers to 
Paneth cells. Scale bar represents 20 µm. 
(B) Frequency of Mex3a-high cells per crypt (n = 72 crypts).  
(C) Frequency of the position of Mex3a-high cells in small intestine crypts (n = 51 
Mex3a-high cells in 72 crypts).  
(D) Design and expression of the Mex3a reporter allele. (Left) A tdTomato/T2A/Cre-
ERT2/bGHpolyA cassette was inserted in the translation start site of Mex3a. This 
construct results in a transcriptional reporter for Mex3a expression driving a tdTomato 
protein and a tamoxifen inducible Cre recombinase. (Right) Immunofluorescence 
against tdTomato in the small intestine of a Mex3aTom/+ mouse. Scale bar represents 20 
µm. 
(E) Representative FACS profile of dissociated small intestine crypt cell preparations 
from Mex3aTom/+ mice. Mex3a-high cells are defined as the top 20% of the Tomato+ 
population. Frequency of populations is referred to the number of viable epithelial cells. 
(F – H) Relative expression of known ISC genes (F), abundant lineage genes (G), and 
putative crypt +4 cell marker genes (H) in Mex3a populations. Bars depict the mean 
and upper/lower limits of relative expression determined by RT qPCR obtained from a 
representative sorting experiment. 
(I) Selected GO biological processes enriched in Mex3a and/or Lgr5 signatures. GO 






Figure 2: Mex3a expression identifies intestinal label-retaining cells. 
(A) Mex3a identifies cells with elevated expression of p21 and p57. Expression of cell 
cycle inhibitors Cdkn1a (p21/WAF1) and Cdkn1c (p57/KIP2) in Mex3a populations. 
Bars depict the mean and upper/lower limits of relative expression obtained from a 
representative sorting experiment. 
(B) Mex3a is enriched in crypt-base label retaining cells. Lgr5 and Mex3a expression 
data in label-retaining (YFP+) vs proliferative (YFP-) cells. Bars depict the mean and 
upper/lower limits from a representative RT qPCR. 
(C) GSEA analysis of the LRC gene expression signature (Table S4) in Mex3a-high vs 
Mex3a-low cells.  
(D) RT qPCR of LRC genes Rfx6 and Peg3 in Mex3a populations. Bars depict the 
mean and upper/lower limits of relative expression obtained from a representative 
sorting experiment. 
(E) Experimental protocol. Mex3aTom/+/Cyp1a1::H2B-YFP compound reporters were 
generated and LRCs were followed by chasing for 10 days after induction. To ensure 
the analysis of ISC enriched cells, an EphB2 staining was incorporated. Representative 
FACS plots of LRCs (YFP+) in Mex3a-high and Mex3a-neg cells.  
(F) Quantification of the distribution of LRCs in Mex3a-high and Mex3a-neg cells. ***, p 
value < 0.001 in a two-tailed t-test (n = 3 mice). Bars depict the mean ± SEM. 
(G) Experimental design to follow EdU retention. EdU was injected into Mex3aTom/+ 
mice and 10 days later Mex3a-high and Mex3a-neg cells were sorted and stained for 
the presence of EdU by FACS. Representative FACS plots of EdU retention in Mex3a-
high (Left panel) and Mex3a-neg cells (Right panel).  
(H) Quantification of the retention of EdU in Mex3a-high and Mex3a-neg cells. **, p 
value < 0.01 in a two-tailed t-test (n = 3 mice). Bars depict the mean ± SEM. 
 
Figure 3: Lineage tracing from Mex3a-high cells shows a distinct behavior from 
Lgr5-high cells.  
(A) Initial clone position in Mex3a and Lgr5-driven lineage tracing. Representative 
image of a Mex3a GFP+ cell in position +3 (Far left panel), Mex3a GFP+ cell in 
position +4 (Left panel), and an Lgr5 LacZ+ cell in position +2 (Right panel) after 36 
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hours of induction. Scale bars represent 20 µm. (Far right) Position of Mex3a (n = 45) 
and Lgr5 (n = 55) early clones.  
(B) Frequency of small intestine Mex3a-derived clone number / 1000 crypts over time. 
Numbers within bars are the total number of clones observed at each timepoint and 
used for subsequent analysis. Data was obtained from n>3 mice (with > 5 
independently stained sections per mouse) per time point. Bars depict mean +/- SD. 
(C) Clone size distribution over time in small intestine Mex3a-driven tracing. Data is 
presented for tracing after 3 (n = 146 clones), 7 (n = 302 clones), 14 (n = 331 clones), 
21 (n = 65 clones), 28 (n = 61 clones) and >180 days (n = 56 clones). 
(D) Comparison of clone size distribution after 7 days of tracing for Mex3a (n = 302) 
and Lgr5 (n = 72 clones). 
(E) Distribution of Mex3a-derived clones in crypts or villi over time. At least 100 
independent clones were scored per time analyzed. 
(F) Number of labeled crypt base columnar cells (CBCs) in 7 day clones from Mex3a (n 
= 52 clones) and Lgr5 (n = 61 clones) derived tracing. Only clones observed within 
crypts were included in the analysis. 
(G-I) (G) Representative images of Mex3a-derived clones after 3 days of tracing. Scale 
bar represents 20 µm. (H) Representative images of Mex3a derived clones after 7 days 
of tracing. Scale bar represents 20 µm. 
 
Figure 4: Mex3a-high cells are multipotent 
(A) Early Mex3a-derived clones do not express differentiation markers. Pictures show 
representative examples of 3 day GFP+ clones co-stained for markers of Paneth 
(LYZ1, far left), enteroendocrine (CHGA, left), tuft (DCLK1, right) or absorptive cells 
(ANPEP, far right). Arrowhead point towards differentiated cells. Scale bar represents 
20 µm. 
(B-D) 7 day Mex3a-derived clones present multilineage differentiation. (B) Examples of 
1 – 2 cell clones positive for tuft (left) and enteroendocrine (middle) and enterocyte 
(right) markers. (C) Examples of multicellular clones with secretory (left) and absorptive 
(right) cells. Arrowheads point towards GFP+ differentiated cells of the specified 
lineage. Note that multicellular clones are composed of more than a single lineage 
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(Red arrowheads). Scale bar represents 20 µm. (D) Mex3a-derived clones are 
composed of both absorptive and secretory cells. A pan secretory antibody mix (i.e. 
combined anti-CHGA, -DLCK1, -MUC2 and -LYZ1 antibodies) and anti-ANPEP to label 
absorptive cells were used to assess the lineage composition of 7 day Mex3a-derived 
clones. Scale bar represents 20 µm. 
(E) A fraction of Mex3a-derived clones remains undifferentiated after 7 days of tracing. 
(Left) A representative undifferentiated clone that is located within the crypt negative for 
the pan-secretory antibody mix. (Right) Representative small GFP clone negative for 
ANPEP. Scale bar represents 20 µm. 
Figure 5: Mex3a-high cells are a subpopulation of Lgr5+ cells 
(A) Representative FACS plot of small intestine Lgr5-GFP+ cells in Lgr5GFP/+; 
Mex3aTom/+ mice. 
(B - D) Characterization of the Lgr5 subpopulations defined in (A) by RT qPCR analysis 
of known intestinal cell markers. Relative expression of ISC genes (B), abundant-cell 
lineage genes (C), and rare-cell lineage genes (D). Values are normalized to the 
subpopulation with the highest expression of each gene. Data represent the mean of 
four independent sorting experiments. (Full expression data is presented in Table S5). 
(E-F) Mex3a-high/Lgr5-high cells are the most efficient in organoid forming assays. (E) 
Representative images of organoid cultures derived from Mex3a/Lgr5 subpopulations. 
(F) Quantification of organoid forming efficiency. Bars depict mean ± SEM (n = 6). *, p 
< 0.05; ***, p < 0.001 in a two-way ANOVA followed by Tukey´s multiple comparison 
test. 
(G-H) Mex3a-high/Lgr5-high cells self-renew and are multipotent in vitro. (G) 
Experimental approach to study self-renewal and multipotency in vitro. (H) Mex3a-
high/Lgr5-high derived organoids were stained for stem/progenitor cells (EPHB2), 
enterocytes (ANPEP), enteroendocrine cells (CHGA), Paneth cells (LYZ1), tuft cells 
(DCLK1) and goblet cells (MUC2). Arrowheads point towards stained cells within 
organoids. Scale bar represents 20 µm. 
 
Figure 6: Single cell transcriptomics identifies a subpopulation of Lgr5-high cells 
enriched in the Mex3a signature. 
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(A) (Left) FACS plot of Lgr5-GFP+ cells obtained from the small intestine of an 
Lgr5GFP/+ mouse. (Right) Experimental pipeline to obtain single cell RNA transcriptomic 
profile of Lgr5 GFP-high cells. 
(B) Principal component analysis of 245 Lgr5-high cells unbiasedly identifies two 
distinct clusters of cells. Each point represents a single Lgr5-high cell. 
(C) Violin plots of relative expression of ISC genes Lgr5, Smoc2, Axin2, and Olfm4 
between Cluster 1 and Cluster 2. 
(D) The Lgr5-signature is equally expressed in Clusters 1 and 2. (Left) Mean 
expression of the Lgr5-signature plotted in each Lgr5-high cell. Lines are drawn on the 
edges of clusters to facilitate their visualization. (Right) Box-plots of relative expression 
of the Lgr5-signature in Cluster 1 and Cluster 2. n.s., p > 0.05 in Kruskal-Wallis test. 
(E) The Mex3a-signature is enriched in Cluster 2. (Left) Mean expression of the 
Mex3a-signature plotted in each Lgr5-high cell. Lines are drawn on the edges of 
clusters to facilitate their visualization. (Right) Box-plots of relative expression of the 
Lgr5-signature in Cluster 1 and Cluster 2. ***, p < 0.001 in Kruskal-Wallis test with at 
least 10% fold change. 
(F) There is no correlation between Mex3a and Lgr5 signatures. Pearson correlation of 
the mean expression of the Lgr5-signature with the Mex3a-signature. 
(G) The Ki67 signature is enriched in Cluster 1. (Left) Mean expression of the Ki67-
signature plotted in each Lgr5-high cell. Lines are drawn on the edges of clusters to 
facilitate their visualization. (Right) Box-plots of relative expression of the Ki67-
signature in Cluster 1 and Cluster 2. ***, p < 0.001 in Kruskal-Wallis test with at least 
10% fold change. 
(H) The Mex3a-signature is inversely correlated with the Ki67-signature. Pearson 
correlation of the mean expression of the Ki67-signature with the Mex3a-signature. 
 
Figure 7: Mex3a-expressing cells are resistant to 5FU and radiation. 
(A) Experimental setup to assess stress response. Mice were treated with either two 
consecutive doses of 5-FU (100 mg/kg per day) or ionizing radiation (12 Gy in one 
day). Mex3a and Lgr5 populations were analyzed by FACS 48h after the final dose. 
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(B) Mex3a-high cells are more resistant to stress than Lgr5-high cells. Quantification of 
Lgr5-high (Left) and Mex3a-high (right) cells in control (n = 4), 5-FU (n = 5) and IR (n = 
4) treated mice. *, p < 0.05; ***, p < 0.001 in a one-way ANOVA followed by Tukey´s 
multiple comparison test. 
(C) Representative FACS plots of Lgr5-GFP+ cells from untreated (left panel), 5-FU 
treated (middle panel), and IR treated (right panel) Lgr5GFP/+; Mex3aTom/+ compound 
mice. Frequencies are referred to total Lgr5-GFP+ cells. 
(D) Quantification of Mex3a populations within Lgr5-high cells in control (n = 4), 5-FU 
treated (n = 5) and IR treated (n = 4) mice. n.s., p > 0.05; ***, p < 0.001 in a two-way 
ANOVA followed by Sidak´s multiple comparison test to untreated mice. 
(E) Quantification of Mex3a populations within Lgr5-low cells in control (n = 4), 5-FU 
treated (n = 5) and IR treated (n = 4) mice. ***, p < 0.001 in a two-way ANOVA followed 
by Sidak´s multiple comparison test to untreated mice. 
(F-G) (F) Experimental setup. Tracing was induced with tamoxifen and followed by two 
doses of 5-FU. Clones were assessed at shown timepoints. (G) Clone-size distribution 
in control and 5-FU treated mice at 3 (Control n = 146 clones; 5-FU n = 134 clones), 7 
(Ctrl n = 302 clones, 5-FU n = 170 clones) and 14 days (Ctrl n = 331 clones, 5-FU n = 
113 clones) from the initial Tamoxifen treatment. Data was obtained from n>4 mice (> 5 




CONTACT FOR REAGENT AND RESOURCE SHARING 
 
Further information and requests for reagents may be directed to, and will be fulfilled by 
the corresponding author, Dr. Eduard Batlle (eduard.batlle@irbbarcelona.org). 
 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
All experimental protocols involving mice were approved by institutional and 
governmental ethics board. Mex3atm1(tdTomato-T2A-CreERT2)EBa were generated at the 
Institute for Research in Biomedicine (IRB) Barcelona. Lgr5tm1(cre/ERT2)Cle mice have 
been previously described (Barker et al., 2007) and were obtained from the laboratory 
of Dr. Hans Clevers. Tg(Cyp1a1-H2B-YFP)Dwi mice have been previously described 
(Buczacki et al., 2013) and were obtained from the laboratory of Dr. Douglas J Winton. 
Reporter strains Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo and Gt(ROSA)26Sortm1Sor have 
been previously described (Muzumdar et al., 2007; Soriano, 1999), and were obtained 
from The Jackson Laboratory. Mex3a reporter mice were used to identify the 
population within the mouse small intestine that expresses this gene. To assess their 
proliferation rate, lineage tracing and overlap with the small intestine Lgr5 population, 
Mex3a mice were crossed with the different models described above. For these in vivo 
experiments, age and sex-matched littermates were always used, with n >3 mice in all 
experiments (detailed description and number of mice are detailed in the respective 




Analysis of ISC signatures:   
 
To identify robust ISC genes we compared three lists of ISC expression signatures 
derived from mouse and small intestine populations. We overlapped the expression 
profile of three different ISC signatures: The first is the small intestine Lgr5-GFP-hi 
signature (GEO dataset: GSE36497) (Muñoz et al., 2012) , which is defined as those 
genes enriched in Lgr5-high compared to Lgr5-low cells in both Agilent and Affymetrix 
platforms (Fold change > 2, p value < 0.05). The second is the previously characterized 
human EPHB2 derived signature (Jung et al., 2011), which is defined by those genes 
enriched in EPHB2-high cells in a graded manner (i.e. EPHB2-high > EPHB2-med > 
EPHB2-low. Fold chage > 2, p value < 0.05). The third signature is obtained from 
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mouse colon Lgr5-GFP cells defined as follows those genes enriched over 2.5 fold in 
Lgr5-GFP-high compared to Lgr5-GFPlow cells (no p value was used as cut-off). 
Consistent ISC genes were those present in all signatures (Table S1). 
 
Generation of the Mex3a reporter allele:   
 
A cassette bearing a tdTomato/T2A/Cre-ERT2/bGH polyA was inserted in frame with 
the Mex3a start codon in exon 1. The targeting vector was generated by Genebridges. 
The vector was verified by restriction enzyme digestion as well as sequencing. The 
vector was electroporated into W4 mouse embryonic stem cells (mESCs) and stably 
transfected cells were selected with G418. After this, single colonies were picked and 
triplicate plates were generated of resistant clones. The clones were then screened by 
long range PCR by using the SequalPrep Kit (Invitrogen). Positive clones were then 
expanded and further analyzed by Southern Blot (as described in (Barker et al., 2007)) 
to assure correct and unique genomic integration. The clones verified by southern blot 
were then transfected with an FlpO-bearing plasmid to remove the Neomycin 
resistance. Single clones were picked and screened by PCR for recombination and 
presence of the reporter cassette. Positive clones were then expanded and analyzed 
by Southern once again to ensure the appropriate integration of the cassette, as well 
as to independently confirm the deletion of the Neomycin resistance cassette. Finally, 
positive clones were selected and blastocyst injection was done to generate chimeras. 
The chimeras with successful germline transmission were bred with C57Bl6 mice and 
the offspring was used to generate the final mouse colonies. mESC culture, blastocyst 
injection of selected clones and generation of chimeras were conducted in the Mouse 
Mutant Core Facility of IRB Barcelona following institutional guidelines. See Table S7 
for genotyping primers. 
 
Mouse models:   
 
Lgr5tm1(cre/ERT2)Cle mice have been previously described (Barker et al., 2007) and were 
obtained from the laboratory of Dr. Hans Clevers. Tg(Cyp1a1-H2B-YFP)Dwi mice have 
been previously described (Buczacki et al., 2013) and were obtained from the 
laboratory of Dr. Douglas J Winton. Reporter strains Gt(ROSA)26Sortm4(ACTB-tdTomato,-
EGFP)Luo and Gt(ROSA)26Sortm1Sor have been previously described (Muzumdar et al., 
2007; Soriano, 1999), and were obtained from The Jackson Laboratory. Mice were 
housed and bred according to IRB Barcelona and PCB institutional guidelines.  
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Lineage tracing:  
 
Rationale: For lineage tracing in the Mex3aTom/+ we used CAG-driven mTmG cassette 
inserted in the ROSA26 locus. We used this model due to the high sensitivity of this 
allele, which allows the identification of very low number of recombination events. In 
the case of Lgr5GFP/+ model, we turned to the ROSA26 lox-stop-lox LacZ model since 
the Lgr5-driven GFP would be confounded with the recombination of the 
ROSA26mTmG cassette. 
 
Dosage: For lineage tracing experiments in the Mex3aTom/+ model, mice were injected 
with two consecutive intraperitoneal doses of tamoxifen (20 mg/kg, Sigma). For early 
time points (i.e. 36 hours), mice were treated with a single dose of 4-OH tamoxifen (5 
mg/kg, Sigma). For lineage tracing from the Lgr5GFP/+ model, 1 dose of diluted 
Tamoxifen (2 mg/kg) was used to ensure tracing from single cell conditions. The time 
of tracing is referred to the first dose of Tamoxifen. 
 
Clone identification: In the case of Mex3aTom/+ mice, the presence of tdTomato in the 
mTmG cassette is confounded with the Mex3a-driven tdTomato. Thus for all lineage 
tracing experiments, intestines were stained to detect GFP+ cells by either IHC or 
immunofluorescence (IF) without considering the tdTomato signal. In the case of Lgr5-
driven tracing, intestines were stained to detect β-galactosidase activity. (See below for 
the protocols used for staining). 
 
Timepoints for tracing: Clone scoring was performed at 36 h (n = 11 mice), 3 days (n = 
6 mice), 7 days (n = 12 mice), 14 days (n = 9 mice), 21 days (n = 4 mice), 28 days (n = 
4 mice) and after 6 months (n = 3 mice) for Mex3a-driven lineage tracing. Lgr5-driven 
lineage tracing was assessed at 36 h (n = 3 mice) and 7 days (n = 3 mice). At least 5 
independent sections were stained per mouse and clones were scored according to 
their size and position (see below). For tracing after 5-FU treatment, clone scoring was 
performed at 3 days (n = 4 mice), 7 days (n = 6 mice) and 14 days (n = 8 mice) after 
the final dose of Tam. 
 
Clone scoring:  
 
Position: GFP+ or LacZ+ clones were scored for their position in three categories: crypt 
base (crypt position +1/+2); suprabasal (crypt position +3/+4) and “crypt top or villus” 
(clone outside of the crypt base). Clone position was only assessed when clones were 
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unequivocally localized in each of these compartments (i.e. clones spanning crypts and 
villi were discarded from the analysis.) 
 
Size: GFP+ or LacZ+ clone size was estimated by counting the number of cells. Clones 
were then classified as single cells, two-cell clones, small clones (3-20 cells), large 
clones (>20 cells) and ribbons. Clones were scored as ribbons only when GFP+ or 
LacZ+ cells were present both at the crypt base (position +1/+2) and up to the tip of the 
villus in the section analyzed. 
 
CBC clone number: Number of crypt-base columnar cells were assessed in clones 
localized at the crypt base where the orientation of the crypt allowed assessment of 
CBC positions from +1 to +4. Since we focused on sections were we could observe the 
crypt-villus axis, the maximum number was 8 CBCs per crypt. 
 
Lineage bias: In order to analyze potential differentiation bias of the Mex3a population, 
7 day clones were co-stained for GFP and either absorptive (ANPEP) or a pan-
secretory antibody mix (CHGA, DCLK1, LYZ1, MUC2). The 7 day tracing time was 
chosen because it has the highest diversity in terms of clone position and clone size. 
 
In vivo treatments:  
 
Cyp1a1::H2B-YFP pulse chase experiments: Transgenic mice bearing the 
Cyp1a1::H2B-YFP allele were given 3 intraperitoneal doses of β-napthoflavone (80 
mg/kg, Sigma) over a 36 hour period to induce activity of the Cyp1a1 promoter and 
mark intestinal cells with H2B-YFP as previously described (Buczacki et al., 2013)  . 
After 10 days, intestines were dissociated and stained for EPHB2 (see below for 
detailed staining protocol). EPHB2-high cells that retained H2B-YFP mark were 
quantified 10 days after the initial dose by flow cytometry (Buczacki et al., 2013).  
 
Label retention assay: For EdU label-retention, Mex3aTom/+ mice were treated with 3 
intraperitoneal doses (1 mg/25 g, Life technologies) in a 36 hour period and analyzed 
10 days after the final dose.  
 
5-FU and IR treatments: Damage to the intestinal epithelium was done by injecting two 
intraperitoneal doses of 5-fluorouracil (100 mg/kg, Sigma) over a 48h period or 12 Gy 
of γ-radiation from a Cs source. For FACS of single and compound reporters, intestinal 
cells were analyzed 48h after the last 5-FU dose. For FACS analysis 4-5 mice (age and 
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sex-matched littermates) were analyzed per group. Treatments were randomized but 
no blinding was incorporated. For lineage tracing experiments mice were injected with 
tamoxifen, treated with 5-FU (100 mg/kg, Sigma) and analyzed at 3, 7 or 14 days after 
the first dose of Tamoxifen (refer to lineage tracing section for exact number of clones 
and mice analyzed per timepoint). 
 
Crypt purification and staining: 
Intestinal crypt cells were purified as previously described (Merlos-Suárez et al., 2011). 
Proximal small intestines (duodenum and jejunum) were dissected from age and sex-
matched mice and cut open longitudinally. They were later incubated with HBSS EDTA 
(8 mM) for 5 min at room temperature. After this incubation, intestines were shaken 
vigorously to remove villi and the first supernatant was discarded. The intestines were 
then incubated with HBSS EDTA on ice for 15 min, after which shaking was repeated. 
This yielded the first crypt fraction. This process was repeated twice and after 
microscopic inspection of the samples the fractions enriched in crypts were kept 
(usually fractions 2 and 3). These fractions were then pooled together for each mouse, 
centrifuged at 1200 rpm for 5 min (4 ºC) and filtered through a 70 μm mesh (BD 
Biosciences) to further remove villi. Filtered fractions were enzymatically disaggregated 
by adding dispase (0.4 mg/mL, Gibco) and incubated for 20 min at 37ºC. The media 
was then supplemented with 5% FBS (Gibco) to neutralize dispase and the samples 
were filtered through a 40 μm mesh. For intestinal LRC analysis in compound reporter 
mice, single cells were stained with an APC-conjugated antibody raised against EphB2 
(Clone mAb 2H9, 6 µg/mL, BD). Cells were stained with DAPI (1 µg/mL, Sigma Aldrich) 
to exclude dead cells. The single-cell preparations of small intestinal crypts were 
analyzed by flow cytometry in a FACS Aria 2.0 (BD). Data was analyzed with 
FACSDiva software (BD) or FlowJo for EdU retention assays.  
 
Population gating rationale: To define subpopulations with the reporter mice we used 
the following criteria: for the Mex3a reporter allele, Tomato-high cells were defined as 
the top 20% brightest cells within the Tomato+ population. For the Lgr5 reporter allele, 
GFP-high cells were defined as the top 25% of the GFP+ population. For compound 
reporter mice, only the GFP+ population was analyzed due to mosaicism of the Lgr5-
GFP allele and Mex3a gates were defined within the Lgr5-GFP high and Lgr5-GFP low 
populations. For all experiments a Mex3a+/+ mouse was processed in parallel to set 
the sorting gates in both single and compound reporter FACS experiments. 
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In vitro organoid growth: 
Compound Mex3a / Lgr5 reporter mice were used to isolate the populations expressing 
different levels of Mex3a and Lgr5. As described above, these experiments were done 
by gating the Lgr5::GFP+ cells and isolating single cells from the respective Mex3a-
high, Mex3a-low and Mex3a-neg cells within both Lgr5-high and Lgr5-low populations. 
4500 cells of each population were sorted into organoid growth media (Advanced 
DMEM/F12 supplemented with Glutamax, HEPES, B27, recombinant EGF (50 ng/mL), 
recombinant NOGGIN (100 ng/mL), recombinant RSPO1 (500 ng/mL) and Y27632 (10 
M). Sorted cells from each population were seeded in three independent Matrigel 
drops (1500 cells/drop). Media was changed every 48 hours and organoid formation 
was quantified 10 days after seeding. To assess organoid formation in stem cell 
conditions, CHIR99021 (3 m) and Valproic acid (1 mM) were added to the cultures. To 
test the self-renewal of Mex3a-high Lgr5-high cells, established organoids were serially 
passaged in Matrigel every 7 days and kept in culture for over 8 passages. To test for 
multipotency, Mex3a-high Lgr5-high derived organoids were formalin fixed and paraffin 
embedded. Sections were then stained for EPHB2, LYZ1, CHGA, ANPEP, MUC2 and 
DCLK1 with standard IF protocols (see below for details and refer to Table S7 for 
antibodies and concentrations used). 
 
RT qPCR analysis:  
 
RNA was extracted from sorted cells by using the Trizol Reagent (Life technologies) 
following manufacturer´s instructions. The only modification was the addition of 
glycogen (40 ng/mL, Roche) to the aqueous phase to visualize the RNA pellet after 
precipitation. RNA was quantified using a Nanodrop and cDNA was produced with the 
High-Capacity cDNA Reverse Transcription kit (Applied Biosystems) following 
manufacturer´s instructions. For experiments with low cellular yield, cells were directly 
sorted on lysis buffer and subjected to cDNA amplification as previously described 
(Gonzalez-Roca et al., 2010). To assess changes in expression of selected genes RT-
qPCR was done with their respective TaqMan probes or primers for SYBR Green. For 
TaqMan assays the TaqMan Universal PCR Master Mix (Applied Biosystems) was 
used. In the case of SYBR Green reactions the Power SYBR Master Mix (Applied 
Biosystems) was used. To calculate gene expression to a normalization gene the 
comparative threshold cycle method was used. See Table S7 for a list of Taqman 
assays and SYBR primers used. 
 
GO Analysis:  
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A signature for Mex3a-high cells was derived by filtering genes differentially expressed 
with a p value < 0.05 and a fold change > 2 fold compared to Mex3a-low cells. The 
previously defined Lgr5 mRNA cell signature (Muñoz et al., 2012) was used. These 
signatures were then analyzed with the DAVID analysis platform and the GO biological 




Tissue fixation: Intestines were processed and cut longitudinally to expose villi. They 
were fixed in formalin for 24h at room temperature and later processed for paraffin 
embedding as previously described (Merlos-Suárez et al., 2011). 
 
Tissue staining: Paraffin sections were processed for standard histological staining as 
previously described (Merlos-Suárez et al., 2011). Antibody concentrations for IHC are 
shown in Table S7. For the detection of tdTomato by immunofluorescence (IF), primary 
anti tdTomato antibody was incubated overnight at room temperature followed by an 
incubation with HRP-coupled polymer (Envision+). After this incubation, a tyramide-
biotin conjugation was performed and later stained with streptavidin-Alexa532 following 
manufacturer´s instructions (Perkin Elmer). β-galactosidase staining was performed as 
previously described (Barker et al., 2007). 
 
GSEA Analysis:  
We ranked all genes measured in Mex3a-high and Mex3a-low cells by microarrays 
according to differential expression between the two populations. We then assessed 
the enrichment of the LRC signature (LRC genes > 2 fold, p value < 0.05 when 
compared to both Paneth and crypt cycling cells. For details refer to Table S4) between 
phenotypes against the ranked file using GSEA. To validate the statistical relevance of 
the enrichment, the enrichment score of 1000 random signatures of matching size was 
computed and compared to the signature of interest. GSEA analysis was performed 
using the implementation from the Broad Institute (Merlos-Suárez et al., 2011; 
Subramanian et al., 2005). 
In situ hybridization:  
Single-molecule in situ hybridization was performed using Advanced Cell Diagnostics 
RNAscope 2.5 HD detection kit (REF 322360) with a probe against Mex3a RNA (REF 
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318531). Small intestines from 4-month old mice were formalin fixed for 24 hours, 
paraffin-embedded and cut into 5-micron thick slices. The single-molecule ISH protocol 
was followed according to manufacturer’s instructions with the following modifications: 
1) after deparafinization and rehydration, tissue was fixed in 10% formaldehyde/PBS 
for 16 hours prior to pretreatment steps, 2) protease treatment for 20 minutes, and 3) 
Amp5 incubation for 20 minutes. Images were acquired with an Olympus BX43 upright 
microscope and DP73 color camera. 
Transcriptomic analysis:  
25 ng of RNA from sorted cells were used to hybridize mouse M430 PM strip 
microarrays (Affymetrix). For Lgr5 colon cells, a pool of proximal colon epithelium from 
5 different mice was used to obtain the necessary material. In the case of Mex3a and 
Mex3a/Lgr5 populations, proximal small intestine epithelium was used. All samples 
were age and sex matched. Affymetrix arrays were normalized using RMA background 
correction and summarization (Irizarry et al., 2003) as implemented in the "affyPLM" 
package from the R statistical framework . Annotations for the "HT-430_PM" array 
version na34 were downloaded from Affymetrix. Technical metrics capturing RNA 
degradation, array saturation, noise floor and quantity of starting material were 
computed for each sample as described in (Eklund and Szallasi, 2008). All samples 
passed quality controls. A linear model was fitted to find differentially expressed genes 
between conditions of interest with technical metrics and scan strip as covariates. The 
"lmFit" function from the "limma" package (Ritchie et al., 2015) was used for fitting the 
model. 
 
Single cell RNA sequencing: 
A single cell preparation from the small intestine of Lgr5 GFP/+ mice was obtained as 
described above. After stringent gating, the top 25% of GFP+ cells were collected. 
Isolation of single cells (400 capture sites), cDNA synthesis and amplification were 
performed on the C1 mRNA Seq HT IFCs medium chip (10-17μm) (Fluidigm) with the 
SMARTer Ultra Low RNA Kit (Clonetech). Spike-in artificial transcripts (ERCC RNA 
Spike-In Mix, Ambion) from The External RNA Controls Consortium were added during 
sample preparation as internal control to support subsequent quality control steps 
(Baker et al., 2005). Quantity and quality of cDNA were assessed with a High 
Sensitivity DNA Chip (Agilent Technologies). Libraries were generated by Nextera XT 
DNA Sample Prep Kit (Illumina) and sequenced on a HiSeq 2500 (Illumina) using 100-
bp mode of Truseq Rapid SBS kit v2. Sequencing was carried out as paired-end reads. 
Read one (12 bp) contained cell and unique molecular barcodes (Islam et al., 2014; 
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Kivioja et al., 2012); read two (85 bp) contained the transcript sequence. Primary data 
analysis was carried out with the standard Illumina pipeline. 
Fluidigm C1 HT-Seq technology includes a two-level indexing system, which allows the 
multiplexed sequencing of multiple single cells and library pools. Here, we processed 
10 libraries (up to 40 cells per library) of Lgr5-high cells, with a total number of 
546,853,233 reads. Quality check was performed with FastQC quality control suite. All 
samples reached the quality standards and were processed to deconvolute reads by 
demultiplexing library and cell barcodes. Prior to mapping, reads were filtered for poly-
T sequences. Then, reads were aligned to the mouse reference genome GRCm38.p4 
(Cunningham et al., 2015) using Gencode M8 annotations (Mudge and Harrow, 2015) 
with the GEMTools 1.7.0 RNASeq pipeline (Marco-Sola et al., 2012). In-house scripts 
were used for gene expression quantification based on molecular identifiers. ERCC 
spike-ins were mapped and quantified in parallel. 
QUANTIFICATION AND STATISTICAL ANALYSIS 
 
General experimental design: 
 
For all experiments n represents the number of independent biological replicates. In 
mice experiments, all groups consisted of age and sex-matched littermates. No 
blinding nor sample-size estimations were incorporated to the experimental setup and 
all data points were included in the analyses (i.e. no exclusion criteria was used). For 
the experiments of 5-FU and IR treatments, mice were randomized.  
 
 
General statistical analysis 
 
Graphs and statistical analysis for figures 1, 2, 3, 4, 5 and 7 were done with GraphPad 
Prism 7.0. In these figures n indicates the number of biological replicates (populations 
obtained from independent mice). For panels 2F and 2H, significant differences were 
assessed by a t-test. For panel 7B, a one-way ANOVA was used followed by Sidak´s 
multiple comparison test. For panels 5F and 7D, a two-way ANOVA was used followed 
by Tukey´s multiple comparison test. Asterisks in figures indicate the following: *, p 




Single cell transcriptomic analysis 
 
Filtering and preprocessing of SCS data 
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Cells with a percentage of reads aligning to spikes larger than 40% and exon 
percentage lower than 30% were removed from the dataset. 10 out of 400 cells were 
filtered by this criterion. 
















and quantile normalization was applied to the resulting matrix. The expression matrix 
was further filtered by removing genes with expression in less than 4 cells and cells 
with less than 1000 genes expressed. The minimum expression was set at 4.5. 
Doublets and empty wells were detected by visual inspection of microscopy images (81 
doublets and 24 empty). In order to remove any undetected doublet we performed 
unsupervised clustering and looked for clusters enriched in these categories. First, 
tSNE coordinates (van der Maaten and Hinton, 2008) were computed without removing 
any artifact and clusters were found using Normal Mixture Modeling as implemented in 
the R package “Mclust” with default parameters and variable number of clusters. For 
each cluster we computed the median of the classification uncertainty for empty and 
non-empty cells. Clusters for which this value for empty cells was lower than for non-
empty cells were classified as enriched (3 out of 7 clusters). All cells belonging to this 
cluster with certainty larger than 0.95 were marked as empty wells (65 of 390).  
A similar approach was followed to remove doublets: starting with the dataset without 
low quality or empty cells, clusters were found and defined to be enriched in doublets 
with the same criterion as before except that clusters were only considered to be 
enriched if they contained more than 8% of cells marked as doublets. 2 out of 7 
clusters were classified as enriched and 55 cells were removed from the dataset. 
Analysis of final dataset 
The final dataset consisted of 245 cells after removing visually detected and predicted 
artifacts. The mean number of UMIs per cell was 31630 (min=4459, median=25920 
and max=70040). Count data was normalized as described before and principal 
components were computed using the most variable and expressed genes (top 11% of 
genes according to the median absolute deviation and mean expression). For plotting 
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of the dataset, dimension reduction was performed through tSNE using the “Seurat” R 
package (Satija et al., 2015). In order to detect possible heterogeneity in the data, 
clustering was computed on the first 3 principal components or in the tSNE coordinates 
accordingly. The optimal number of clusters was decided according to the Bayesian 
Information Criterion for expectation-maximization as implemented in the Mclust 
function. 2 clusters were found in both PCA and tSNE analysis. For PCA analysis, 
clusters 1 and 2 were of sizes 140 and 105 cells respectively. For tSNE analysis, 
clusters 1 and 2 were of 165 and 80 cells respectively. Gene set enrichment analysis 
(GSEA) as implemented in (Subramanian et al., 2005) was performed on ranked lists 
by fold change of expression between clusters. Fold changes and p-value for 
differential expression were computed with a bimodal model as implemented in the 
function “find.markers” from the R package Seurat. 
Robustness analysis of clusters   
Downsampling of the total number of UMIs per cell was performed in order to 
investigate the robustness of the resulting clusters. Datasets were simulated 20 times 
for total number of UMIs ranging from 10 to 90% of the original value. Unsupervised 
clustering was repeated as with the original data and the number of clusters and 
expression was stored. The number of clusters remained relatively constant for all 
simulations (Figure S6A). A random forest classifier was fitted to the simulated data 
and original cluster labels. The number of individuals may be important for cluster 
discovery therefore we downsampled our dataset choosing subsets of cells and 
repeating the process. We found that with fewer than 50% of the cells the second 
cluster was lost in half of the simulations and almost completely with 30% of the cells 
(Figure S6B). The out of bag error of classification is depicted (Figure S6C,S6D), 




DATA AND SOFTWARE AVAILABILITY 
 
Microarray data from Mex3a/Lgr5 subpopulations has been deposited in the GEO 
database with the accession number GSE90629. 
 
Single cell transcriptomics of Lgr5-high cells has been deposited in the GEO database 
with the accession number GSE90856. 
 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit anti tdTomato Rockland  Cat# 600-401-379 
Rabbit anti GFP Abcam Cat# ab6556 
Goat anti GFP Abcam Cat# ab6673 
Mouse anti BrdU BD Cat# 347580 
Rabbit anti Lysozyme Dako Cat# A0099 
Goat anti Chromogranin A Santa Cruz Cat# sc-1488 
Rabbit anti Dclk1 Abgent Cat# AP7291b 
Goat anti Anpep RD systems Cat# AF2335 
Rabbit anti Muc2 Santa Cruz Cat# sc-15334 
Goat anti EphB2 APC BD Cat# 564699 
Chemicals, Peptides, and Recombinant Proteins 
Ulex Europaeus Agglutinin I, FITC labeled Sigma Cat# L9006 
5-fluorouracil Sigma Cat# F6627 
Tamoxifen Sigma Cat# T5648 
4-OH Tamoxifen Sigma Cat# H6278 
Beta-napthoflavone Sigma Cat# N3633 
5-ethynyl-2´-deoxyuridine (EdU) Life technologies Cat# A10044 
5-bromo-2´-deoxyuridine (BrdU) Sigma Cat# B5002 
Ethylenediaminetetracetic acid (EDTA) Sigma Cat# E5134 
Dispase ThermoFisher Cat# 17105-041 
Trizol Life technologies Cat# 15596018 
TaqMan Universal PCR Master Mix Applied Biosystems Cat# 4364341 
SYBR Green PCR Master Mix Applied Biosystems Cat# 4368706 
Matrigel BD Cat# 356231 
Recombinant human EGF Peprotech Cat# AF-100-15 
Recombinant human RSPO1 In house n/a 
Recombinant human NOGGIN In house n/a 
CHIR99021 Stemgent Cat# 04-0004-02 
Y27632 Sigma Cat# Y0503 
Valproic Acid Sigma Cat# P4543 
Critical Commercial Assays 
RNAscope 2.5 HD detection kit ACD Cat# 322360 
High-Capacity cDNA Reverse Transcription kit Applied Biosystems Cat# 4368813 
C1 Single-Cell mRNA Seq HT IFC, 10–17 µm Fluidigm Cat# 101-0222 
SMART-Seq v4 Ultra® Low Input RNA Kit Clontech Cat# 635025 
Nextera XT DNA Sample Prep Kit Illumina Cat# FC-131-1096 
Deposited Data 
Microarray analysis of Mex3a Lgr5 populations This paper GEO90629 
Single cell RNA Seq of Lgr5-high cells This paper GEO90856 
Experimental Models: Organisms/Strains 
Mex3atm1(tdTomato-T2A-CreERT2)EBa This paper n/a 
Lgr5tm1(cre/ERT2)Cle Barker et al, 2007 JAX Stock nº: 008875 
Gt(ROSA)26Sortm1Sor Soriano et al, 1999 JAX Stock nº: 003309 
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo Muzumdar et al, 2007 JAX Stock nº: 007576 
Tg(Cyp1a1-H2B-YFP)Dwi Buczacki et al, 2013 n/a 
Sequence-Based Reagents 
ISH Mex3a probe ACD Cat# 318351 
Genotyping and RT qPCR assays Table S7  
Key Resource Table
Software and Algorithms  
affyPLM package  (Irizarry et al., 2003) 
lmFit limma package (Ritchie et al., 2015) 
GEMTools 1.7.0 RNASeq pipeline  (Marco-Sola et al., 
2012) 
tSNE analysis  (van der Maaten and 
Hinton, 2008) 
















































































































































































Positive regulation of cell proliferation
Regulation of sodium ion transport
Wnt receptor signaling pathway
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Mex3a-derived clones after 7 days
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Sort Mex3a-high Lgr5-high cells
Expand organoids in vitro
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p val: 7.8 x 10-10; corr: -0.38












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































                            Supplemental Information 
 
 
Mex3a marks a slowly dividing subpopulation of Lgr5+ 
intestinal stem cells  
 
Francisco M. Barriga, Elisa Montagni, Miyeko Mana, Maria Mendez-Lago, 
Xavier Hernando-Momblona  , Marta Sevillano, Amy Guillaumet-Adkins,Gustavo 
Rodriguez-Esteban, Simon J. A. Buczacki, Marta Gut, Holger Heyn, Douglas J. 
Winton, Omer H. Yilmaz, Camille Stephan-Otto Attolini, Ivo Gut and Eduard 
Batlle 
  
Supplemental Figures & Text
Supplementary Table List 
Table S1 – Gene expression signatures used to define robust ISC genes (Related to 
Figure 1) 
Table S2 – Genes enriched in intestinal Mex3a-high cells (Related to Figure 1) 
Table S3 – GO categories enriched in intestinal Mex3a-high and Lgr5-high cells 
(Related to Figure 1) 
Table S4 – Gene enriched in intestinal label-retaining cells (Related to Figure 2) 
Table S5 – Full RT qPCR relative expression data from Mex3a/Lgr5 subpopulations 
(Related to Figure 5) 
Table S6 – Gene expression signatures used for transcriptional analysis in single cell 
RNA Seq (Related to Figures 6 and S6) 
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Figure S1 – Identification of Mex3a as a robust ISC gene and generation of the Mex3a 
Tom/+ allele (Related to Figure 1).
(A) Overlap of intestinal signatures identifies Mex3a as a novel and robust ISC-specific gene. 
Comparison of Lgr5- derived signatures of mouse small intestine, mouse colon and EphB2-derived 
human colonic stem cell signatures (Refer to Table S1).
(B) RT qPCR analysis of Lgr5 and Mex3a expression in intestinal populations defined by EPHB2 
(left panel) and Lgr5 expression (right panel). Bars depict the mean and upper/lower limits of 
relative expression obtained from a representative sorting experiment.
(C) Generation of the Mex3a knock-in allele reporter mice. Depiction of the WT and targeted 
locus of mouse Mex3a, as well as Southern blots for the 5´and 3´arms of the insertion. 
A representative genotyping PCR is shown.
(D) Representative FACS plot of small intestine crypt cells obtained from a Mex3a+/+ mouse.
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Figure S2 – Mex3a-high cells enrich for LRC genes within the H2B-YFP+ retaining population
(Related to Figure 2).
(A) Mex3a identifies LRCs within the YFP+ intestinal population. Cyp1a1::H2B-YFP mice were 
induced and chased for 10 days. YFP+ cells were divided in Mex3a-high and Mex3a-neg populations 
and analyzed by RT qPCR for ISC and LRC markers. Bars depict the mean and upper/lower limits 
of relative expression obtained from a representative sorting experiment.
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Figure S3 – Lineage tracing from Mex3a Tom/+ allele is derived from Mex3a-high cells
(Related to Figure 3).
(A) Experimental setup to study lineage tracing in Mex3aTom/+; ROSA26mTmG mice 
and Lgr5GFP/+; ROSA26LacZ mice.
(B) Relative expression of CreERT2 levels in Mex3a populations. Bars depict the mean 
and upper/lower limits from a representative RT qPCR.
(C) Relative expression of Mex3a and Cdkn1c in GFP+ and GFP- cells 72 hours 
after tracing. Mex3aTom/+; ROSA26mTmG mice were treated with tamoxifen and 
72 hours after induction GFP+ and GFP- cells were FACS sorted and RNA was extracted f
or low cell number expression assays. Bars depict mean ± upper/lower limit.
(D) Analysis of BrdU incorporation in Mex3a-derived clones 3 days after tracing. 
(Left) Representative picture of a GFP+ clone that is negative for BrdU. 
(Right) Quantification of Brdu+ cells within GFP+ (n > 30 cells) and GFP- (n >150 cells) 
populations of crypts after 3 days of tracing. Scale bar represents 20 
m.
(E) Examples of ribbon clones from a 7 day Lgr5-driven tracing experiment 





Figure S4 - Related to Figure 4
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Figure S4 – Mex3a-derived clones are comprised of all intestinal lineages 
(Related to Figure 4)
(A) Low magnification images of villus clones positive for pan-secretory (left) and 
absorptive (right) markers. Inset shows cells in higher magnification and arrowhead
indicates the positive staining for the respective markers. Scale bar represents 10 m.
(B) Mex3a-high cells give rise to Paneth cells. (Left) Multicellular 7 day clone 
containing Paneth cells (white arrowheads) and undifferentiated cells (red arrow). 
(Right) 7 day clone composed by two Paneth cells (black arrowheads). Scale bar 
represents 20 m.
(C-D) A fraction of Mex3a-derived clones remains undifferentiated after 7 days. 
(C) Representative image of an undifferentiated small clone 7 days after tracing.
(D) Low magnification images of undifferentiated crypt clones 7 days after tracing.
Arrowheads indicate the GFP+ clone. Note that all are located in position +3/+4.
Scale bar represents 20 m.
Figure S5 - Related to Figure 5









































































































High Low High LowMex3a:
Lgr5-high Lgr5-low
Organoid formation in 
stem conditions
Figure S5 – Mex3a-high cells express lower levels of Defa rs1than mature Paneth cells and 
retain their differences in clonogenic potential even under high Wnt/Notch culture conditions 
(Related to Figure 5).
(A) Representative plot of small intestine cells from Lgr5GFP/+; Mex3a+/+ mouse. 
The gates are the ones used to identify Mex3a-Tomato subpopulations in compound 
reporters. Frequencies shown are relative to total Lgr5-GFP cells.
(B) Relative expression of Bmi1, Hopx and Dll1 in Mex3a/Lgr5 populations. 
Values are normalized to the subpopulation with the highest expression of each gene. 
Data represent the mean of two independent sorting experiments.
(C) Defa rs1 expression is highly enriched in differentiated Paneth cells. Small intestine 
cells were stained with UEA-Lectin to sort Paneth cells as well as the different 
Mex3a/Lgr5 populations. Bars depict the mean and upper/lower limits of expression.
(D) Organoid forming capacity of Mex3a/Lgr5 subpopulations in stem cell conditions. 
(Left) Representative images of 7 day organoids derived from Mex3a/Lgr5 
populations. Note that in this conditions organoids are spheres and do not present 
differentiated cells. (Right) Quantification of organoid forming efficiency of Mex3a/Lgr5 
populations in stem conditions. Bars depict mean ± SEM (n = 3).
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Figure S6 – Robustness tests, tSNE visualization and IBP signature expression in Lgr5 single 
cell profiling dataset (Related to Figure 6).
(A) Analysis of the effect of reads/cell on cluster prediction. Predicted cluster 
number is stable upon downsampling of the number of reads/cell.
(B) Analysis of the effect of cell number on cluster prediction. Predicted 
cluster number is affected by a downsampling of over 50% of total cells analyzed.
(C) Analysis of the effect of reads/cell on cell assignation to Cluster 1 or 2. 
The ability to correctly classify a cell into Cluster 1 or 2 is stable even when 
20% of total reads/cell is used.
(D) Analysis of the effect of total cells on cell assignation to Cluster 1 or 2.
(E) The Lgr5-signature is equally expressed in Clusters 1 and 2 defined by tSNE. 
(Upper) Mean expression of the Lgr5-signature plotted in each Lgr5-high cell across clusters
in tSNE dimensions. Lines are drawn on the edges of clusters to facilitate their 
visualization. (Bottom) Box-plots of relative expression of the Lgr5-signature in Cluster 1 
and Cluster 2. n.s., p > 0.05 in Kruskal-Wallis test.
(F) The Mex3a-signature is enriched in Cluster 2 defined by tSNE. (Upper) Mean expression 
of the Mex3a-signature plotted in each Lgr5-high cell across clusters in tSNE 
dimensions. Lines are drawn on the edges of clusters to facilitate their visualization. 
(Bottom) Box-plots of relative expression of the Mex3a-signature in Cluster 1 
and Cluster 2. ***, p < 0.001 in Kruskal-Wallis test.
(G) The Ki67-signature is enriched in Cluster 1 defined by tSNE. (Upper) Mean expression 
of the Ki67-signature plotted in each Lgr5-high cell across clusters in tSNE 
dimensions. Lines are drawn on the edges of clusters to facilitate their visualization. 
(Bottom) Box-plots of relative expression of the Ki67-signature in Cluster 1 
and Cluster 2. ***, p < 0.001 in Kruskal-Wallis test.
(H) Mex3a-high/Lgr5-high signature is enriched in Cluster 2. (Left) Mean 
expression of the Mex3a-high/Lgr5-high-signature plotted in each Lgr5-high cell. 
(Right) Box-plots of relative expression of the Mex3a-high/Lgr5-high-signature in 
Cluster 1 and Cluster 2. ***, p < 0.001 in Kruskal-Wallis test with a minimal 
fold change of 10%.
(I) The intestinal bipotent progenitor (IBP) is not differentially expressed in 
Clusters 1 and 2. (Left) Mean expression of the IBP-signature plotted in 
each Lgr5-high cell. (Right) Box-plots of relative expression of the IBP-high-signature 
in Cluster 1 and Cluster 2.




















































































































































Figure S7 – Behavior and lineage tracing quantification of Mex3a-high cells upon chemotherapy 
and radiotherapy treatments (Related to Figure 7).
(A) Representative FACS plots of small intestine Lgr5-GFP+ cells from control 
(left panel), 5-FU treated (middle panel) and IR treated (right panel) mice. The 
frequency of Lgr5-high cells is shown relative to total Lgr5-GFP cells.
(B) Representative FACS plots of small intestine tdTomato+ cells from control 
(left panel), 5-FU treated (middle panel) and IR treated (right panel) mice. 
The frequency of Mex3a-high cells is shown relative to total Mex3a-tdTomato cells.
(C) Initial clone position in Mex3a-derived tracing is unaffected after 5FU treatment. 
Clone position was assessed at 3 days in control (n = 146 clones) and 5-FU 
(n = 134 clones) treated mice.
(D) Clone frequency is not affected by 5-FU in Mex3a-derived tracing. 
Clones / 1000 crypts were assessed at 3 (Control, n = 146; 5-FU, n = 134), 
7 (Control, n = 302; 5-FU, n = 170) and 14 (Control, n = 331; 5-FU, n = 113) days. 
Bars depict ± SD.
(E) Mex3a-derived clones, excluding ribbons, are largely located at position +4 after 
1 week regardless of 5-FU treatment. Mex3aTom/+ mice were induced with Tamoxifen 
and then treated with two consecutive doses of 5-FU. Representative images in control 
(left panels) and 5-FU treated (right panels) of Mex3a-derived clones 1 week after 
tamoxifen induction. Scale bar represents 20 m.
